References
- CosnesJGower-RousseauCSeksikPCortotAEpidemiology and natural history of inflammatory bowel diseasesGastroenterology201114061785179421530745
- StangeEFTravisSPVermeireSEuropean evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosisJ Crohns Colitis20082112321172194
- GilardiDFiorinoGAlloccaMBravataIDaneseSGolimumab: clinical update on its use for ulcerative colitisDrugs Today (Barc)201551317118425876561
- Schulze-KoopsHGiacomelliRSamborskiWFactors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritisClin Exp Rheumatol201533220120825664404
- KivitzASeguradoOGHUMIRA pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumabExpert Rev Med Devices20074210911617359217
- LasalviaPBarahona-CorreaJERomero-AlverniaDMPen devices for insulin self-administration compared with needle and vial: systematic review of the literature and meta-analysisJ Diabetes Sci Technol201610495996626920639
- RidyardCHDawoudDMTuersleyLVHughesDAA systematic review of patients’ perspectives on the subcutaneous route of medication administrationPatient20169428129226792584
- WongMAbdulnabiRCareyMAFuHA randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naive adults with diabetesCurr Med Res Opin201329546547323438454
- PfutznerASchipperCNiemeyerMComparison of patient preference for two insulin injection pen devices in relation to patient dexterity skillsJ Diabetes Sci Technol20126491091622920818
- PhillipsJTFoxEGraingerWTuccilloDLiuSDeykinAAn open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjectsBMC Neurol20111112621999176
- LimWHChanDBoudvilleNPatients’ perceptions of subcutaneous delivery of darbepoetin alfa by autoinjector prefilled pen versus prefilled syringe: a randomized, crossover studyClin Ther20123491948195322902097
- TandonNBolceRNaimAPMS66 satisfaction with and preference for golimumab and its auto-injector among rheumatoid arthritis patients switched from adalimumab or etanerceptValue Health2012154A45A46
- DemaryWSchwenkeHRockwitzKSubcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experiencePatient Prefer Adherence201481061107125125973
- KivitzACohenSDowdJEClinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trialClin Ther200628101619162917157117
- PfutznerABaileyTCamposCAccuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionalsCurr Med Res Opin201329547548123402225
- CamposCLajaraRDeluzioTUsability and preference assessment of a new prefilled insulin pen versus vial and syringe in people with diabetes, physicians and nursesExpert Opin Pharmacother201213131837184622873943
- PfutznerAAsakuraTSommavillaBLeeWInsulin delivery with FlexPen: dose accuracy, patient preference and adherenceExpert Opin Drug Deliv20085891592518713000
- KorytkowskiMBellDJacobsenCSuwannasariRA multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitusClin Ther200325112836284814693308
- BerteauCSchwarzenbachFDonazzoloYEvaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteersPatient Prefer Adherence2010437938821049090
- LopezABillioudVPeyrin-BirouletCPeyrin-BirouletLAdherence to anti-TNF therapy in inflammatory bowel diseases: a systematic reviewInflamm Bowel Dis20131971528153323518810